Overview
Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, presents a wide spectrum of clinical manifestations from asymptomatic infection to severe respiratory distress and multisystem involvement 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172.Diagnosis
Management
References
Showing 100 most recent of 3280 indexed papers.
1 Vogel G, Kupferschmidt K. Rare, dangerous side effects from COVID-19 vaccines explained. Science (New York, N.Y.) 2026. link 2 Kupferschmidt K. New conflicts erupt over key virus database. Science (New York, N.Y.) 2026. link 3 Amdani S, Altman CA, Chowdhury D, Ronai C, Soma D, Archer JM et al.. Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection. Current pediatric reviews 2026. link 4 Taba M, Fajardo MA, Ferguson E, Keast R, Basseal JM, McCaffery K et al.. Science translation strategies to the public during health emergencies: A systematic review of RCTs. Patient education and counseling 2026. link 5 Almeida AB, Schweigert M, Spieth P, Dubecz A, de Abreu MG, Richter T et al.. Outcome of Emergency Pulmonary Lobectomy under ECMO Support in Patients with COVID-19. The Thoracic and cardiovascular surgeon 2026. link 6 Sun M, Guo J, Li Y, Chen L, Meng Y, Wu J et al.. Post-COVID-19 Syndrome-associated Risk Factors for Acne Exacerbation. Current medicinal chemistry 2026. link 7 Kalidoss S, Velasquez DA, Sloan MJ, Fantus RJ, Chang C, Faris SF. Impact of COVID-19 on Urology Resident Case Volume. Urology 2026. link 8 Suthanawarakul B, Promma N, Iampinyo P, Saraboon C, Wattanaprateep J, Waongenngarm P. Effects of physical therapy via telerehabilitation on cardiopulmonary, physical and psychological function in patients with coronavirus disease 2019: A randomised controlled trial. Journal of telemedicine and telecare 2026. link 9 Silva IVTC, Inoue LH, Brito FAM, Baccon WC, Pesce GB, Höring CF et al.. Prevalence and factors associated with long Covid in older people in the State of Paraná. Revista da Escola de Enfermagem da U S P 2026. link 10 Freitas NL, Oliveira RD, Santos AKDS, Cunha-Filho M, Medeiros-Souza P. Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients. PloS one 2026. link 11 Rahimnahal S, Yousefizadeh S, Mohammadi Y. Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches. PloS one 2026. link 12 Debnath D, Tripura U, Debbarma J. Are Coronavirus Disease 2019 Vaccinations Causing Fatal Adverse Event? A Comprehensive Case Discussion Based on WHO Adverse Events Following Immunization Causality Criteria. Annals of African medicine 2026. link 13 Ganmaa D, Cook KA, Khudyakov P, Enkhjargal D, Bilegtsaikhan T, Mayer KH et al.. A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 Trial. The Journal of nutrition 2026. link 14 Yesenia Rodríguez-Tanta L, Delgado-Escalante R, Del Pilar Solis-Yucra T, Rojas EC, Lozada GA, Veramendi-Espinoza LE et al.. Post-marketing safety surveillance of the BBIBP-CorV (Sinopharm) COVID-19 vaccine in Peruvian healthcare workers: A retrospective analysis of a Pharmacovigilance Center. Vaccine 2026. link 15 Riad A, Attia S. Disproportionality analysis of oral adverse events following COVID-19 vaccination: Investigating demographic disparities and notoriety bias using a hybrid frequentist-Bayesian approach. Dental and medical problems 2026. link 16 Silva RMA, Nóbrega MEBD, Percio J, Martins AF, Almeida SLR, Porto VBG. Signals of disproportionate reporting of events supposedly attributable to COVID-19 vaccines in children and adolescents: case-non-case study, Brazil, 2022. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil 2026. link 17 Ordóñez-Mena JM, Gu X, Joy M, Fan X, Meza-Torres B, Hinton W et al.. Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 18 Foroshani S, Airo M, Levine A, Frishman WH, Aronow WS, Lanier GM. COVID-19 and Pulmonary Hypertension: An Interesting Dynamic. Cardiology in review 2026. link 19 Buschner A, Fedeli U, Zoppini G. The association of obesity and other metabolic disorders with COVID-19 mortality: a cross-sectional analysis of death certificates from Veneto (Italy) and Bavaria (Germany). Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 20 Chen Y, Li H, Ma Y, Wang L, Qian G, Li S et al.. Evaluating the effectiveness and safety of Azvudine for hospitalised patients with COVID-19 and hypertension: a multicenter retrospective cohort study. Scientific reports 2026. link 21 Karaviti D, Charakida M, Dimopoulou D, Marmarinos A, Papadaki M, Maritsi D et al.. Long term cardiovascular effects on COVID-19 infection in children. The need for monitoring. International journal of cardiology 2026. link 22 Briones-Claudett KH, Briones-Zamora KH, Benites Solís J, Touriz Bonifaz MA, Berrus Zhumi E, Briones-Zamora AD et al.. Reverse Takotsubo Syndrome Triggered by COVID-19-Associated Cytokine Storm: Unveiling a Novel Pattern of Myocardial Dysfunction in SARS-CoV-2 Infection. The American journal of case reports 2026. link 23 Taxiarchis A, Antovic J, Rooyackers O, Dumitrescu G. High complement expression on extracellular vesicles in Covid-19 patients without pulmonary embolism leading to death. Case report. Immunology letters 2026. link 24 Miyamori D, Ito M. Impact of COVID‑19 infection on subsequent prescriptions of autonomic dysfunction pharmacotherapy: a nationwide propensity‑score‑matched Cohort study in Japan. Annals of medicine 2026. link 25 Koskinen M, Ruotsalainen E, Wallin M, Kivelä H, Carlsson K, Petäjä J et al.. Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned. Thrombosis research 2026. link 26 Faghir-Ganji M, Abdolmohammadi N, Ansari-Moghaddam A, Askari S, Eshrati B. COVID-19 vaccination and stroke risk: A systematic review and meta-analysis of ischemic and hemorrhagic events. Journal of infection and public health 2026. link 27 Chen AL, Robbins M, Masters S, Boudiab E, Finn D, Peshel E et al.. Examining the role of thromboelastography in patients with COVID-19. Perfusion 2026. link 28 Rodrigues P, Mota S, Amaral C, Garganta B, Catalão C, de Almeida L et al.. Impact of . Frontiers in public health 2026. link 29 Egashira Y, Watanabe R. Changes in rehabilitation service utilisation during COVID-19 bed surges in Japan: a seasonal autoregressive integrated moving average (SARIMA) analysis of care utilisation with 10-year claims data. BMJ open 2026. link 30 Hernán MA, Álvaro-Meca A, Calvo-Alcántara MJ, Navarro Gómez ML, Ramos JT, Estévez JC et al.. Effectiveness and Safety of COVID-19 mRNA Vaccines in Children 6-17 Years Old: A Population-based Study in Madrid. The Pediatric infectious disease journal 2026. link 31 Morales-Demori R, Ortoleva J, Aras S, Anders M. Outcomes of Extracorporeal Membrane Oxygenation in Patients with COVID-19 and Pulmonary Hypertension: An ELSO Registry Analysis. Journal of cardiothoracic and vascular anesthesia 2026. link 32 Aynekulu Mersha DG, Lopuhaä B, Gietema HA, Smit J, Wind AE, Hulshof AM et al.. In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome. Journal of thrombosis and haemostasis : JTH 2026. link 33 Alonso Fernández MÁ, Bledig C, Manso Álvarez M, Gómez Guardiola R, Blancas García M, Bartolomé I et al.. SARS-CoV-2 vaccination reduces the risk of thrombotic complications in severe COVID-19. Medicina intensiva 2026. link 34 Jiang Z, Shan T, Li Y, Han F, Feng B, Zhen X et al.. Persistent attenuation of lymphocyte subsets after mass SARS-CoV-2 infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 35 Oyama S, Matsunaga A, Teratake Y, Takahashi H, Yamashita H, Ishizaka Y et al.. COVID-19-associated large-vessel vasculitis with elevated anti-angiotensin converting enzyme 2 antibody: three cases and a review of the literature. Clinical rheumatology 2026. link 36 Verma S, Lan NSR, Espedal H, Ong J, Roy A, Ahmad A et al.. Persistent lung and vascular inflammation in mild to moderate COVID-19 survivors detected by ¹⁸F-FDG PET/CT: A quantitative imaging study with implications for cardiovascular risk. European journal of nuclear medicine and molecular imaging 2026. link 37 da Fonseca CC, Perazzo H, Cardoso SW, Tavares ICF, Ribeiro MPD, Moreira RC et al.. Deep Vein Thrombosis in Critically Ill Patients With COVID-19 Pneumonia: Incidence, Wells Score Diagnostic Performance, and Hospital Prognosis. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2026. link 38 Jones AE, Khan Z, McGroder CF, Murphy SO, Depender C, Mira-Sanchez M et al.. Post-Acute Sequelae of COVID-19 Persist Over 3 Years in Acute Lung Injury/Acute Respiratory Distress Syndrome Survivors But Are Not Associated With Persistent Thromboinflammation or Endothelial Dysfunction. Critical care explorations 2026. link 39 Wada H, Shiraki K, Ichikawa Y, Ito N, Inoue H, Moritani I et al.. Implications of Soluble C-Type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis. Thrombosis and haemostasis 2026. link 40 Schreckenberg R, Woitasky N, Itani N, Czech L, Windhorst AC, Juchem M et al.. mRNA-based SARS-CoV-2 vaccines: intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress. Frontiers in immunology 2026. link 41 Leberzammer J, Abplanalp WT, Grikscheit K, Solomonidis EG, Glaser SF, Schuhmacher B et al.. Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells. Cardiovascular research 2026. link 42 Lindgren M, Sjöland H, Djekic D, Robertson J, Åberg M, Thunström E et al.. Long-term risk of cardiovascular events after COVID-19 in the Swedish adult population-A matched cohort study. Journal of internal medicine 2026. link 43 Smolinski M, Chew JL, Constantinescu C, Buchan CA, Burton C, Carignan A et al.. Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study. Human vaccines & immunotherapeutics 2026. link 44 Pouy R, Bermejo M, Durlach A, Bani-Sadr F. Cutaneous leukocytoclastic vasculitis leading to extensive digital necrosis as the only COVID-19 clinical manifestation. Vascular diseases (Paris, France) 2026. link 45 Siegal DM, Tseng EK, Schünemann HJ, Angchaisuksiri P, Cuker A, Dane K et al.. American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary. Blood advances 2025. link 46 Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A et al.. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. The New England journal of medicine 2025. link 47 Yoon SH, Kanne JP, Ashizawa K, Biederer J, Castañer E, Fan L et al.. Best Practice: International Multisociety Consensus Statement for Post-COVID-19 Residual Abnormalities on Chest CT Scans. Radiology 2025. link 48 Kumar SS, Calabrese EC, Slater BJ, Lin C, Hong J, Dort J et al.. SAGES guidelines update to laparoscopy in the era of COVID-19. Surgical endoscopy 2025. link 49 Berner R, Ravens-Sieberer U, Strahwald B, Blankenburg J, Kaman A, Topf S et al.. S3-Guideline on Measures for the Prevention and Control of SARS-CoV-2 Transmission in Schools. Klinische Padiatrie 2025. link 50 Kriaučionienė V. Lifestyle and Health Changes During and After the COVID-19 Pandemic: Insights from This Special Issue. Nutrients 2025. link 51 Roush K. Health Care Workforce Rebounds Post-COVID-19. The American journal of nursing 2025. link 52 Cohen J. NIH cancels research grants for COVID-19 and future pandemics. Science (New York, N.Y.) 2025. link 53 Gillani MKUH, Sajid MK. The Need for a Multidimensional Approach to Mortality Prediction in COVID-19: A Critical Review of Recent Findings. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2025. link 54 Roush K. COVID-19 Infection Shown to Increase the Risk of Adverse Cardiac Events. The American journal of nursing 2025. link 55 Li Y, Wei J, Lan C, Liu Y. Inappropriate antidiuretic hormone secretion syndrome following COVID-19 infection misdiagnosed as cerebral infarction. Endokrynologia Polska 2025. link 56 Mori N, Mikamo H, Kunishima H, Yanagihara K, Sasaki J, Mukae H et al.. A web questionnaire-based survey on post-COVID-19 condition for infectious disease specialists in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2025. link 57 Tscharntke LT, Jung N, Hanses F, Koll CEM, Pilgram L, Rieg S et al.. Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort. Infection 2025. link 58 Economidis I. Biopolitics and the Ethical Dilemmas of Biotechnology: Lessons From the Pandemic. Microbial biotechnology 2025. link 59 Genç Perdecioğlu GR, Yürük D, Akkaya ÖT. My back hurts! Did you have COVID-19 infection?. Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology 2025. link 60 Imazio M, Basso C, Brucato A, Klingel K, Kuchynka P, Lazaros G et al.. Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal 2025. link 61 Briggs B, Mulekar M, Morales H, Husain I. Comparison of an Emergency Medicine Asynchronous Learning Platform Usage Before and During the COVID-19 Pandemic: Retrospective Analysis Study. JMIR medical education 2025. link 62 Bahra J, Acharya A, Ather S, Benamore R, Moreland JA, Gulati D et al.. Improving the accuracy of emergency department clinicians in detecting SARS-COV-2 on chest X-rays using a bespoke virtual training platform. BMC medical education 2025. link 63 Yu X, Wang J. Framing Celebrity Scientists: How Chinese Media and Public Construct Celebrity-Based Risk Communication in Public Health Emergencies. Health communication 2025. link 64 Martínez-Cabezas S, Díaz Del Castillo A, Linares-García J, Niño-Machado N, Idrovo AJ, Ruiz-Rodríguez M et al.. The invisible frontline: experiences of public health workers during the COVID-19 pandemic and health emergencies in Colombia. Frontiers in public health 2025. link 65 Yakushin MA, Kabaeva EN, Seliverstov KО, Vorobeva AV. [The Innovative Technology of Life Support of Low Mobile Citizens in Conditions of Emergency Situation]. Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny 2025. link 66 Liu J, Wang Y, Song Y, Li Q. Understanding the layout of emergency scientific research during COVID-19 prevention and control: a comparative analysis of project solicitation and project approval. BMC public health 2025. link 67 Niu Z, Gao Y, Wu X, Hu Q, Hu D. How online public opinion evolves before and after policy adjustments in response to major public health emergencies. Frontiers in public health 2025. link 68 Budrie L. Disproportionality and discrimination in public health emergencies: Lessons from Trinidad and Tobago's COVID-19 cremation ban. Developing world bioethics 2025. link 69 Chen H, Cao Z, Zhang X, Duan H, Jiang S, Cai C. The association between perceived stress and resilience among medical staff during public health emergencies: mediating effect of self-efficacy. BMC psychology 2025. link 70 Shamsi-Gooshki E, Parsapoor A, Moosavi S. Ethical challenges in conducting research in low and middle income setting during public health emergencies: a qualitative evidence of a COVID-19 pandemic: the experience of Iran. BMC medical ethics 2025. link 71 Yang F, Huang X, Huang W, Jiang T. Development and testing of a public health emergency intelligence analysis system based on text analysis and NLP analysis. Frontiers in public health 2025. link 72 Ramezani R, Zhang W, Cao M, Bui A, Petruse A, Weldon A et al.. Remote Patient Monitoring for Global Emergencies: Case Study in Patients With COVID-19. JMIR formative research 2025. link 73 Guilamo-Ramos V, Benzekri A, Williams D, Thimm-Kaiser M, Wizentier MM, Goodman M et al.. A nurse-led clinical practice model to increase healthcare reach among underserved families during public health emergencies: A randomized controlled trial. Nursing outlook 2025. link 74 Zhang Y, Guo Y. To tier or not to tier: the institutionalization of the World Health Organization's power to determine pandemic emergency in the amended International Health Regulations (2005). Global health research and policy 2025. link 75 Jie-Ying Z, Jun L, Xue-Ya W, Rui-Xue F, Feng Z, Yi T et al.. The practice of drug emergency supply in China during the COVID-19 pandemic: A policy mix perspective. PloS one 2025. link 76 Liu T, Ma Z. A study of Chinese law on restricting personal liberty for public health protection: taking the COVID-19 epidemic as the entry point. Frontiers in public health 2025. link 77 Rahman-Shepherd A, Cutter J, Hinjoy S, Ho ZJM, Huimin JC, Miranda I et al.. ASEAN and the COVID-19 pandemic: a scoping review on the role and response of a regional organisation in a global health emergency. BMJ global health 2025. link 78 Sánchez-Gambetta S, Arrunategui-Salas G, Barrios-Morocho JL, Hora RA, Pérez-Buitrago S, Castañeda B et al.. Performance assessment of a ventilator developed for emergency use in a resource-constrained ICU setting during the COVID-19 pandemic. Biomedical engineering online 2025. link 79 Wang Y, Wei M, Wang P, Gao Y, Yu T, Meng N et al.. Insight into public sentiment and demand in China's public health emergency response: a weibo data analysis. BMC public health 2025. link 80 Wang YZ, Xu Y, Ren LZ, Wang Y, Xu YH, Wang YF. The impact of uncertainty stress and social support on the occupational well-being of healthcare professionals during public health emergencies. Work (Reading, Mass.) 2025. link 81 Chatzaraki V, Kubik-Huch RA, Potempa A, Gashi A, Friedl A, Heesen M et al.. Preoperative chest computed tomography in emergency surgery during COVID-19 pandemic. Journal of perioperative practice 2025. link 82 Hemmat K, Amri M, Eisenkraft Klein D. How have PHEIC determinations changed since the COVID-19 pandemic? A document analysis of 101 WHO International Health Regulations Emergency Committees' statements. BMC public health 2025. link 83 Bulat V, Šitum M, Filipović N, Delaš Aždajić M, Crnarić I. TELEDERMATOLOGY AS A TRIAGE METHOD DURING THE COVID-19 PANDEMIC AND EARTHQUAKE AFTERMATH IN ZAGREB. Acta clinica Croatica 2025. link 84 Lin Z, Ding Y, Gan X, Wang J, Zheng H, Li W et al.. Improvement of Pre-check and Triage Efficiency and Guarantee of Maternal and Infant Safety in Pandemic Situation. Alternative therapies in health and medicine 2025. link 85 Bragazzi NL, Buchinger M, Atwan H, Tuma R, Chirico F, Szarpak L et al.. Proficiency, Clarity, and Objectivity of Large Language Models Versus Specialists' Knowledge on COVID-19's Impacts in Pregnancy: Cross-Sectional Pilot Study. JMIR formative research 2025. link 86 Heise M, Madi M, Mattern E, Stengler A, Steckelberg A. Effects of the COVID-19 pandemic on working conditions of maternity staff - a scoping review. BMC pregnancy and childbirth 2025. link 87 Spronz RG, Dudovitz RN, Thomas K, Szilagyi PG, Vizueta N, Vangala S et al.. Changes in School-Age Children's Well-being and School-Related Needs Post COVID-19 Pandemic. Clinical pediatrics 2025. link 88 Zhou B, Xu Q, Li S, Wang J, Liu J, Zhang T et al.. Impact of Omicron infection on childhood health: the Beijing long-COVID study. Frontiers in public health 2025. link 89 Johnson G, Espàrza A, Stevenson E, Stadler L, Ensor K, Williams S et al.. Schools and Wastewater Surveillance: Practical Implications for an Emerging Technology to Impact Child Health. Health promotion practice 2025. link 90 Romano ME, Buckley JP, Li X, Herbstman JB, Kannan K, Lee S et al.. Changes in urinary concentrations of contemporary and emerging chemicals in commerce during the COVID-19 pandemic: Insights from the Environmental influences on Child Health Outcomes (ECHO) program. PloS one 2025. link 91 Peterson MD. 2024 Emery A. Rovenstine Memorial Lecture: Our Finest Hour-How Anesthesiologists Saved Countless Lives during the COVID-19 Pandemic. Anesthesiology 2025. link 92 Al-Taie SF, Fedwi MM, Merza M, Alshahrani MY, Rekha MM, Kundlas M et al.. Evaluation of different sedation scales in the ICU management of COVID-19 patients. Scientific reports 2025. link 93 Clark JR, Batra A, Tessier RA, Greathouse K, Dickson D, Ammar A et al.. Impact of healthcare system strain on the implementation of ICU sedation practices and encephalopathy burden during the early COVID-19 pandemic. GeroScience 2025. link 94 Loudet CI, Sarubbio MG, Meschini MJ, Becerra JV, Mazzoleni MA, Aramendi V et al.. Analgesia, sedation, and neuromuscular blocking agents: A standardized protocol of analgosedation in COVID-19. Medicina intensiva 2025. link 95 da Silva MM, Viana DR, Colucci MG, Gonzaga LA, Arcuri JF, Frade MC et al.. Effects of a cardiopulmonary telerehabilitation using functional exercises in individuals after COVID-19 hospital discharge: A randomized controlled trial. Journal of telemedicine and telecare 2025. link 96 Chang HH, Lee YH, Huang KC, Chan DC, Lin YC, Sheng WH et al.. COVID-19 vaccination: 2023 Taiwan Association of Gerontology and Geriatrics (TAGG) consensus statements. Journal of the Formosan Medical Association = Taiwan yi zhi 2025. link 97 Gavazova E, Staynova R, Grekova-Kafalova D. Inappropriate polypharmacy during the COVID-19 pandemic: impact, challenges, and solutions - a narrative review. Folia medica 2025. link 98 Graf A, Reichardt B, Wagenlechner C, Krotka P, Traxler-Weidenauer D, Mildner M et al.. Baseline medication load and long-term outcomes in COVID-19-hospitalized patients: results of the AUTCOVSTUDY. Frontiers in public health 2025. link 99 Shakib SH, Antimisiaris D. Analysis of polypharmacy in older adults pre- and post-COVID-19. Expert review of clinical pharmacology 2025. link 100 Mao M, Du S, Xu Y, Li Q, Luo R, Zhou Q et al.. Polypharmacy or potentially inappropriate medications among older adults with COVID-19 in a secondary hospital in China and their association with mortality. Scientific reports 2025. link